If so, you may be eligible to participate in an important clinical research program. The Novartis clinical research study, known as Record-2, is investigating the drug RAD001 in patients with Kidney Cancer. You may be eligible to participate if you are:
18 years of age or older
Diagnosed with cancer in the kidney that has spread to other organs in your body
Participants will be monitored closely throughout their treatment by highly trained doctors and nurses who specialize in kidney cancer research and treatment. If you would like to see if you qualify to participate in a Novartis research study, click on the button below.
|
|
 |
|
|
Sign up and receive information about clinical trials in your health-related areas of interest. For U.S. residents only.
|
|
Non-U.S. residents
